US 11285139
Treatment of CNS conditions
granted A61KA61K31/444A61K31/4545
Quick answer
US patent 11285139 (Treatment of CNS conditions) held by Takeda Pharmaceutical Company Limited expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/444, A61K31/4545, A61K45/06, A61P